CHECKMATE GOVERNMENT RELATIONS

Lobbying for PHARMAESSENTIA USA CORPORATION · Biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · $110,000.00 income · posted Jul 17, 2026

Lobbying activity 1

Health Issues

Issues related to orphan drugs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem